Back
Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Cidara Therapeutics Industry Stock Comparison
Sell
35
VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF
Last Price:
$83.33
Seasonality Move:
-0.83%
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$63.02
Seasonality Move:
2.01%
Sell
35
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT)
is a Sell
Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.02. The Score for VCIT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
VCIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCIT Stock Price Chart
What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?
-
The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $83.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $62.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
VCIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.39 | Buy |
Relative Strength Index (14 RSI): | 60.03 | Buy |
Chaikin Money Flow: | 16979811 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.17 - 82.99) | Buy |
Bollinger Bands (100): | (80.82 - 82.48) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.72 | Buy |
Relative Strength Index (14 RSI): | 66.1 | Buy |
Chaikin Money Flow: | -71329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.74 - 63.84) | Buy |
Bollinger Bands (100): | (16.87 - 51.01) | Buy |
VCIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 83.05 | Sell |
20-day SMA: | 82.7 | Buy |
50-day SMA: | 82.25 | Buy |
200-day SMA: | 81.35 | Buy |
8-day EMA: | 77.77 | Buy |
20-day EMA: | 55.39 | Buy |
50-day EMA: | 29.54 | Buy |
200-day EMA: | 8.64 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.11 | Sell |
20-day SMA: | 61.15 | Buy |
50-day SMA: | 46.89 | Buy |
200-day SMA: | 27.08 | Buy |
8-day EMA: | 58.14 | Buy |
20-day EMA: | 41.46 | Buy |
50-day EMA: | 22.13 | Buy |
200-day EMA: | 6.48 | Buy |
Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |